Special items: Ovarian Cancer and Us blog best viewed in Firefox

▼

Friday, March 12, 2010

Medicare Establishes Reimbursement Coverage for Vermillion's OVA1(TM) Test - financial news

"FREMONT, Calif., March 12, 2010 /PRNewswire via COMTEX/ -- Vermillion, Inc. (Pink Sheets: VRML) today announced that Medicare will cover OVA1(TM), a test to help assess the likelihood that an ovarian mass is benign or malignant. Highmark Medicare Services is the CMS contractor that will process Medicare claims for OVA1. Yesterday Highmark announced its decision to cover this new service....."

No comments:

Post a Comment

Your comments?

Note: Only a member of this blog may post a comment.